Neurosteer Overview
Neurosteer has developed a solution designed for early detection and more effective treatment of a variety of neurological disorders. Its platform consists of a medical-grade wearable device and a cloud-based system that provide real-time monitoring and assessment of brain activity. The companys current focus is on delivering objective biomarkers to identify the early onset of Parkinsons disease, Alzheimers disease, dementia, and epilepsy. Neurosteer uses an adhesive forehead strip connected to a pocket-sized device that wirelessly transmits sensor data to the cloud for proprietary signal processing. Advanced algorithms then decompose the single EEG channel into over 100 individual components for real-time analysis and display on a web-based dashboard. The results are more affordable screening, continuous patient monitoring, and optimized neurostimulation and drug selection, leading to improved neurological treatment and clinical trial outcomes.
Cumulative Funding Raised Over Time ($)
$2.5MSep 2015
Latest News
growth-positive
Neurosteer pursues wearable device to detect Alzheimer's
Israeli company Neurosteer, founded by CEO Nathan Intrator, has developed a wearable device that can remotely evaluate patients for their risk of developing neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, and frontotemporal dementia. The device consists of a three-electrode strip that is placed on the patients forehead and uses signal processing, artificial intelligence, and machine learning to produce biomarkers linked to brain states and neurological disorders. Neurosteer is currently conducting clinical trials in multiple countries and hopes to obtain FDA approval for its device in 2020. The company has received over $5 million in investments from individuals with personal connections to neurodegenerative disorders. The device is expected to have a positive impact on the companys growth.
CustomersInvestment
growth-positive
New monitoring tool could revolutionize brain treatment
Neurosteer, an Israeli company, has developed the worlds first miniature, wearable continuous brain-activity monitor. The device, currently in clinical trials, offers a more user-friendly alternative to traditional EEG and fMRI exams. It is inexpensive, portable, and can be used on a 24/7 basis. The device wirelessly transmits sensor data to a cloud-based server, allowing for continuous brain monitoring and analysis. Neurosteer is expected to receive FDA approval this year for neurodegenerative or epilepsy monitoring. The device has the potential to be used for initial assessment of neurological disorders, as well as in drug development and discovery. Neurosteer has raised approximately $5 million in funding and is seeking partners to develop additional applications for its technology.
CustomersInvestment
growth-positive
Cracking the Code on Mobile Brain Monitoring -Nathan Intrator, Neurosteer-Full
Nathan Intrator, founder of Neurosteer and professor of computer science, discusses the progress his company has made in the development of new applications for brain monitoring. Intrator believes that home monitoring will have a significant impact on patients and the general population, and that Israel’s evolving digital health ecosystem is playing a key role in this progress. He also talks about the potential for brain monitoring in the gaming industry, and the intersection of brain monitoring with virtual and augmented reality.
Expand
Neurosteer: introducing a novel brain activity monitor
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.56M |
| Last funding | $58.4K |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.neurosteer.com |
Locations
Arieh Shenkar St 1, Herzliya, Israel
375 South End Avenue, New York, NY, USA
Photos & Videos
3 item(s)
Neurosteer Business
Business models
B2C, B2B
Product stage
Clinical Trial
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical MonitorsDiagnostics DevicesTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesPharmaceuticalsCore Technology
Artificial IntelligenceMachine LearningData StorageCloudSemiconductors & ElectronicsWearablesSensingTags (28)
diagnosticsneurologymonitoringdigital-healthcaresignal-processingalzheimers-diseasesensorshospitalshealthcare-providersemotions-analyticsepilepsydata-analyticsbig-datapatientsnon-invasiveartificial-intelligencewearableneurosciencemachine-learningmedical-devicescloud-basedpharma-companiesearly-detectionbiomarkerswellnesshome-carebrain-disorderremote-monitoringNeurosteer Financials
$2.56M
Total funding
Undisclosed
Capital raised
$58.4K
Last funding
Seed
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$2.5MSep 2015
Private Equity Funding
Seed
Sep 2015
$2.5M
Arkady Volozh
Non-Equity Funding
GrantEvent
Jun 2018
$58.4K
EU Horizon 2020
Neurosteer Lifecycle
Cumulative Funding Raised Over Time
$2.5MSep 2015
All Events
Seed
Sep 2015
$2.5M
Arkady Volozh
GrantEvent
Jun 2018
$58.4K
EU Horizon 2020
Neurosteer News
4 articles
growth-positive
Neurosteer pursues wearable device to detect Alzheimer's
Israeli company Neurosteer, founded by CEO Nathan Intrator, has developed a wearable device that can remotely evaluate patients for their risk of developing neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, and frontotemporal dementia. The device consists of a three-electrode strip that is placed on the patients forehead and uses signal processing, artificial intelligence, and machine learning to produce biomarkers linked to brain states and neurological disorders. Neurosteer is currently conducting clinical trials in multiple countries and hopes to obtain FDA approval for its device in 2020. The company has received over $5 million in investments from individuals with personal connections to neurodegenerative disorders. The device is expected to have a positive impact on the companys growth.
CustomersInvestment
growth-positive
New monitoring tool could revolutionize brain treatment
Neurosteer, an Israeli company, has developed the worlds first miniature, wearable continuous brain-activity monitor. The device, currently in clinical trials, offers a more user-friendly alternative to traditional EEG and fMRI exams. It is inexpensive, portable, and can be used on a 24/7 basis. The device wirelessly transmits sensor data to a cloud-based server, allowing for continuous brain monitoring and analysis. Neurosteer is expected to receive FDA approval this year for neurodegenerative or epilepsy monitoring. The device has the potential to be used for initial assessment of neurological disorders, as well as in drug development and discovery. Neurosteer has raised approximately $5 million in funding and is seeking partners to develop additional applications for its technology.
CustomersInvestment
growth-positive
Cracking the Code on Mobile Brain Monitoring -Nathan Intrator, Neurosteer-Full
Nathan Intrator, founder of Neurosteer and professor of computer science, discusses the progress his company has made in the development of new applications for brain monitoring. Intrator believes that home monitoring will have a significant impact on patients and the general population, and that Israel’s evolving digital health ecosystem is playing a key role in this progress. He also talks about the potential for brain monitoring in the gaming industry, and the intersection of brain monitoring with virtual and augmented reality.
Expand
Neurosteer: introducing a novel brain activity monitor
Neurosteer Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 12 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 19 classification IDs that could be used for matching.
Neurosteer Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515297265 |
| Crunchbase | neurosteer-ltd |
| Creator | Noy Barak |
| Creator email | bn.barak.noy@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wain@gmail.com |
| Last update | 2022-06-29T00:00:00.000Z |
| Created | 2015-07-17T00:00:00.000Z |
| Claimed | Yes |